 SAN DIEGO, Sept. 13, 2021 PRNewswire -- Inhibrx, Inc. NASDAQ: INBX, a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today that the Company will be presenting at the following upcoming virtual investor conference: 2021 Cantor Virtual Global Healthcare Conference; Wednesday, September 29th, at 8:40 a.m. 